Chasing the Cure: Drug Tolerance and Targeted Therapy in Breast Cancer

Breast cancer research has made remarkable strides in recent years, but the challenge of drug tolerance continues to demand innovative solutions. Join us for an in-depth conversation with Dr. Nandini Verma, a renowned oncologist and researcher at the forefront of cancer therapeutics, as we delve into the complex yet hopeful journey toward precision medicine.

In this engaging session, Dr. Verma will illuminate the latest advancements in targeted therapies that are reshaping how breast cancer is treated. From understanding the mechanisms behind drug resistance to exploring cutting-edge treatment modalities, this event promises to shed light on both the hurdles and breakthroughs in the field.

Expect to uncover:

• The science behind targeted therapies and their pivotal role in modern oncology.

• How researchers are tackling the pressing issue of drug tolerance in breast cancer patients.

• Real-world case studies and insights into what the future holds for personalized cancer care.